Skip to main content

Advertisement

Log in

The neoplastic potential of columnar-lined (Barrett's) esophagus

  • World Progress In Surgery
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Reflux of gastric contents is the most important factor contributing to the development of a columnar-lined esophagus (CLE). CLE should be considered a “mosaic” of cells, glands, and architectural types showing variable degrees of maturation towards intestinal and gastric epithelium. Dysplasia refers to an unequivocally neoplastic alteration in the epithelium. High-grade (severe) dysplasia consists of neoplastic cellular and/or architectural changes within the columnar epithelium, without invasion through the basement membrane. The prevalence of dysplasia is usually 5% to 10%. Dysplasia has been found in the vast majority in the specialized columnar-type or intestinal-type epithelium. Adenocarcinoma in CLE is most often seen in males. At the time of diagnosis transmural tumor infiltration is found in 60% to 88% of patients, and lymph node invasion in 55% to 74% of patients. The prognosis is poor with a low 5 year survival. Estimates of incidence of cancer vary from 1 case per 52 patient years of follow-up to 1 case per 441 patient years of follow-up.

Résumé

Le reflux du contenu gastrique est le facteur le plus important qui contribue au développement de l'endobrachyoesophage. L'endobrachyoesophage pourrait être considéré comme une “mosaīque” de cellules, de glandes et types d'architectures, présentant des degrés variables de maturation vers l'épithélium intestinal et gastrique. La dysplasie consiste en une altération néoplasique indiscutable de l'épithélium. Une dysplasie sévére (de grade élevé) comporte des cellules néoplasique et/ou des modifications architecturales de l'épithélium cylindrique sans franchissement de la membrane basale. La prévalence de la dysplasie est habituellement de l'ordre de 5 à 10%. La dysplasie est, dans la majorité des cas, mise en évidence dans l'épithélium cylindrique ou intestinal. L'adénocarcinome au sein de l'endobrachyoesophage est retrouvé principalement chez l'homme. Au moment du diagnostic, une infiltration tumorale transpariétale est retrouvée dans 60 á 88% des cas, et un envahissement ganglionnaire dans 55 à 74% des cas. Le pronostic est mauvais avec un taux faible de survié à 5 ans. L'estimation de l'incidence de cancer est variable, allant de 1 cas sur 52 á 1 cas sur 441 patients par année de suivi.

Resumen

El reflujo del contenido gástrico es el factor más importante en el desarrollo del esófago de Barret. El esófago de Barrett debe ser considerado como un “mosaico” de células, glándulas y tipos arquitectónicos, que exhiben grados variables de maduración hacia el epitelio intestinal y gastrico. El termino displasia se refiere a una inequívoca alteracion neoplásica del epitelio. El alto grado (severo) de displasia consistente en cambios celulares neoplásicos y/o arquitectónicos del epitelio columnar, sin invasión de la membrana basal. La incidencia de la displasia es usualmente del orden de 5–10%. La displasia ha sido hallada principalmente en el epitelio del tipo columnar especializado o intestinal. El adenocarcinoma en el esófago de Barrett se observa principalmente en hombres. En el momento del diagnóstico la infiltración transmural del tumor se encuentra con una incidencia de 60–88%, y la invasión de nódulos linfáticos con incidencia de 55–74% de los casos. El pronóstico es pobre, on baja posibilidad de sobrevida a 5 años. La incidencia estimada de cáncer varía desde 1 caso por 52 a 1 caso por 441 pacientes año de seguimiento.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Endo, M., Kobayashi, S., Kozu, T., Takemoto, T., Nakayama, K.: A case of Barrett epithelization followed up for five years. Endoscopy18(suppl 3):11, 1974

    Google Scholar 

  2. Savary, M., Monnier, P.: Diagnosis, pathophysiology and adenocarcinogenesis of Barrett's esophagus. In Esophageal Disorders: Pathophysiology and Therapy, T.R. DeMeester, D.B. Skinner, editors, New York, Raven, pp. 101–8, 1985

    Google Scholar 

  3. Thompson, J.J., Zinsser, K.R., Enterline, H.T.: Barrett's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction. Hum. Pathol.14:43, 1983

    Google Scholar 

  4. Levine, D.S., Rubin, C.E., Reid, B.J., Haggitt, R.C.: Specialized metaplastic columnar epithelium in Barrett's esophagus: A comparative transmission electron microscopy study. Lab. Invest.60:418, 1989

    PubMed  Google Scholar 

  5. Hameeteman, W., Tytgat, G.N.J., Houthoff, H.J., van den Tweel, J.G.: Barrett's esophagus, development of dysplasia and adenocarcinoma. Gastroenterology96:1249, 1989

    PubMed  Google Scholar 

  6. Hameeteman, W.: Columnar-lined (Barrett's) esophagus. Thesis, University of Amsterdam 1989; Drukkery All Zn B.V., Katwijk, The Netherlands

  7. Wesdorp, I.C.E., Bartelsman, J., Schipper, M.E.I., Offerhaus, J., Tytgat, G.J.: Malignancy and premalignancy in Barrett's esophagus: A clinical, endoscopical, and histological study of 100 patients. Gastroenterology11:317, 1981

    Google Scholar 

  8. Morson, B.C., Sobin, L.H., Grundmann, E., Johansen, A., Nagayo, T., Serck-Hansen, A.: Precancerous conditions and epithelial dysplasia in the stomach. J. Clin. Pathol.33:711, 1980

    PubMed  Google Scholar 

  9. Riddell, R.H.: Dysplasia and regression in Barrett's epithelium. In Barrett's Esophagus: Pathophysiology, Diagnosis, and Management, S.J. Spechler, R.K. Goyal, editors, New York, Elsevier, pp. 143–52, 1985

    Google Scholar 

  10. Reid, R.J., Haggitt, R.C., Rubin, C.E., Rabinovitch, P.S.: Barrett's esophagus: Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology93:1, 1987

    PubMed  Google Scholar 

  11. Schmidt, H.G., Riddell, R.H., Walther, B., Skinner, D.B., Riemann, J.F.: Dysplasia in Barrett's esophagus. J. Cancer Res. Clin. Oncol.110:145, 1989

    Google Scholar 

  12. Kerlin, P., D'Mellow, G., van Deth, A.: Barrett's esophagus: Clinical, endoscopic, and histologic spectrum in fifty patients. Aust. N.Z. J. Med.16:198, 1986

    PubMed  Google Scholar 

  13. Hamilton, S.R., Smith, R.R.L., Cameron, J.L.: Prevalence and characteristics of Barrett's esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum. Pathol.19:942, 1988

    PubMed  Google Scholar 

  14. Haggitt, R.C., Dean, P.J.: Adenocarcinoma in Barrett's epithelium. In Barrett's Esophagus: Pathophysiology, Diagnosis, and Management, S.J. Spechler, R.K. Goyal, editors, New York, Elsevier, pp. 153–66, 1985

    Google Scholar 

  15. Monnier, P.H., Frontolliet, C., Savary, M., Ollyo, J.B.: Barrett's oesophagus or columnar epithelium of the lower oesophagus. Bailliere's Clin. Gastroenterol.1:769, 1987

    Google Scholar 

  16. Skinner, D.B., Walther, B.C., Riddell, R.H., Schmidt, H., Iascone, C., DeMeester, T.R.: Barrett's esophagus: Comparison of benign and malignant cases. Ann. Surg.198:554, 1983

    PubMed  Google Scholar 

  17. Reid, R.J., Weistein, W.M., Lewin, K.J.: Endoscopic biopsy detect early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology94:81, 1988

    PubMed  Google Scholar 

  18. Palley, S.L., Sampliner, R., Garewal, H.S.: Editorial: Management of high-grade dysplasia in Barrett's esophagus. J. Clin. Gastroenterol.11:369, 1989

    PubMed  Google Scholar 

  19. Robertson, C.S., Mayberry, J.F., Nicholson, D.A., James, P.D., Atkinson, M.: Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br. J. Surg.75:760, 1988

    PubMed  Google Scholar 

  20. Schnell, T., Sontag, S., Chejfec, G., Chintam, R., O'Connell, S., Kurucar, C.: High grade dysplasia in Barrett's esophagus: Experience with 36 patients (abstract). American College of Gastroenterology, October 23, 1989

  21. Hamilton, S.R., Smith, R.R.L.: The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in the Barrett's esophagus. Am. J. Clin. Pathol.87:301, 1987

    PubMed  Google Scholar 

  22. Haggitt, R.C., Tryzelaar, J., Ellis, F.H., Colcher, H.: Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am. J. Clin. Pathol.70:1, 1978

    PubMed  Google Scholar 

  23. Skinner, D.B.: En bloc resection for neoplasms of the esophagus and cardia. J. Thorac. Cardiovasc. Surg.85:59, 1983

    PubMed  Google Scholar 

  24. Steiger, Z., Wilson, R.E., Leichman, L., Busuito, M.J., Rosenberg, J.C.: Primary adenocarcinoma of the esophagus. J. Surg. Oncol.36:68, 1987

    PubMed  Google Scholar 

  25. Sanfey, H., Hamilton, S.R., Smith, R.R.L.: Carcinoma arisin in Barrett's esophagus. Surg. Gynecol. Obstet.161:570, 1985

    PubMed  Google Scholar 

  26. Witt, T.R., Bains, M.S., Zaman, M.B., Martini, N.: Adenocarcinoma in Barrett's esophagus. J. Thorac. Cardiovasc. Surg.85:337, 1983

    PubMed  Google Scholar 

  27. Smith, R.R.L., Hamilton, S.R., Boinott, J.K., Rogers, E.L.: The spectrum of carcinoma arising in Barrett's esophagus. Am. J. Surg. Pathol.8:563, 1984

    PubMed  Google Scholar 

  28. Rosenberg, J.C., Budev, H., Edwards, R.C.: Analysis of adenocarcinoma in Barrett's esophagus utilizing a staging system. Cancer55:1353, 1985

    PubMed  Google Scholar 

  29. Skinner, D.B., Walther, B.C., Little, A.G.: Surgical treatment of Barrett's esophagus. In Barrett's Esophagus: Pathophysiology, Diagnosis, and Management, S.J. Spechler, R.K. Goyal, editors, New York, Elsevier, pp. 211–21, 1985

    Google Scholar 

  30. Bremner, C.G., Hamilton, D.G.: Barrett's esophagus: Controversial aspects. In Esophageal Disorders: Pathophysiology and Therapy, T.R. DeMeester, D.B. Skinner, editors, New York, Raven, pp. 233–9, 1985

    Google Scholar 

  31. Cameron, A.J., Ott, B.J., Payne, W.S.: The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N. Engl. J. Med.313:857, 1985

    PubMed  Google Scholar 

  32. Cameron, A.J., Zinsmeister, A.R., Ballard, D.J., Carney, J.A.: A population-based study of Barrett's esophagus: Comparison of clinically diagnosed prevalence versus autopsy determined prevalence. Gastroenterology94:A57, 1988

  33. Spechler, S.J., Schimmel, E.M., Dalton, J.W., Doos, W., Tries, J.S.: Barrett's epithelium complicating lye ingestion with sparing of the distal esophagus. Gastroenterology81:580, 1981

    PubMed  Google Scholar 

  34. Sprung, D.J., Ellis, F.H., Gibb, S.P.: Incidence of adenocarcinoma in Barrett's esophagus. Am. J. Gastroenterol.79:817A, 1984

  35. Sampliner, R.E.: Editorial. Does Barrett's esophagus need to be detected? Arch. Intern. Med.96:438A, 1986

  36. van der Veen, A.H., Dees, J., Blankensteijn, J.D., van Blankenstein, M.: Adenocarcinoma in Barrett's oesophagus: An overrated risk. Gut30:14, 1989

    PubMed  Google Scholar 

  37. Atkinson, M.: Barrett's oesophagus: To screen or not to screen? Gut30:2, 1989

    PubMed  Google Scholar 

  38. Wesdorp, I.C.E., Bartelsman, J., Schipper, M.E.I., Tytgat, G.N.: Effect of long-term treatment with cimetidine and antiacids in Barrett's oesophagus. Gut22:724, 1981

    PubMed  Google Scholar 

  39. Sampliner, R.E., Garewal, H.S., Fennerty, M.B. Aickin, M.: Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Dig. Dis. Sci.35:93, 1990

    PubMed  Google Scholar 

  40. Perniceni, T., Leymarios, J., Molas, G., Fekete, F.: L'endobrachy-oesophage regresse-t-il apres diversion duodenale totale? Gastroenterol. Clin. Biol.12:709, 1988

    PubMed  Google Scholar 

  41. DeViere, J., Buset, M., Dumonceau, J.M., Rickaert, F., Cremer, M.: Regression of Barrett's epithelium with omeprazole. N. Engl. J. Med.320:1497, 1989

    PubMed  Google Scholar 

  42. Spechler, S.J.: Barrett's esophagus: What's new and what to do. Am. J. Gastroenterol.84:220, 1989

    PubMed  Google Scholar 

  43. Dent, J.: Approaches to oesophageal columnar metaplasia (Barrett's oesophagus). Scand. J. Gastroenterol.24(suppl 168):60, 1989

    Google Scholar 

  44. Spechler, S.J.: Endoscopic surveillance for patients with Barretts' esophagus: Does the cancer risk justify the practice? Ann. Intern. Med.106:902, 1987

    PubMed  Google Scholar 

  45. Achkar, E., Carey, W.C.: The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. Am. J. Gastroenterol.83:291, 1988

    PubMed  Google Scholar 

  46. Garewal, H., Leibovitz, A., Sampliner, R., Prabhata, R., Trent, J., Korc, M., Sloan, D.: Tissue culture and characterization of epithelial cells devised from Barrett's esophagus, a premalignant lesion. Gastroenterology94:A143, 1988

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tytgat, G.N.J., Hameeteman, W. The neoplastic potential of columnar-lined (Barrett's) esophagus. World J. Surg. 16, 308–312 (1992). https://doi.org/10.1007/BF02071538

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02071538

Keywords

Navigation